
Ran Bio-Pharma Private Limited
Founded in 2011 and headquartered in Andhra Pradesh, India.
Founded in 2011 and headquartered in Andhra Pradesh, India.
Visakhapatnam, Andhra Pradesh, India
+91-XXXXXXXXXX
U24232AP2011PTC075293
075293
Private Limited Indian Non-Government Company
30 Jun 2011
31 Dec 2012
31 Mar 2012
Unlisted
Roc Vijayawada
Name | Designation | Appointment Date | Status |
---|---|---|---|
Tumarada Rao ![]() | Director | 30-Jun-2011 | Current |
Rongali Naidu ![]() | Director | 30-Jun-2011 | Current |
Enhance accessibility to Ran Bio-Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Ran Bio-Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Rongali Naidu is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ran Bio-Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ran Bio-Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ran Bio-Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ran Bio-Pharma Private Limited last Annual general meeting of members was held on 31 Dec 2012 as per latest MCA records.
Ran Bio-Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2012 with Roc Vijayawada.
Tumarada Chandra Mouliswara Rao was appointed as a Director was appointed as a Director on 30 Jun 2011 & has been associated with this company since 13 years 10 months .
Rongali Atchum Naidu was appointed as a Director was appointed as a Director on 30 Jun 2011 & has been associated with this company since 13 years 10 months .
Ran Bio-Pharma Private Limited was registered on 30 Jun 2011 with Roc Vijayawada & aged 13 years 10 months as per MCA records.
Ran Bio-Pharma Private Limited was incorporated on 30 Jun 2011.
The authorized share capital of Ran Bio-Pharma Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Ran Bio-Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Ran Bio-Pharma Private Limited is 14-37-33B Beside Vijay Medical Centre Krishna Nagar, Maharanipeta India, Visakhapatnam, Andhra Pradesh, 530002.
The corporate identification number (CIN) of Ran Bio-Pharma Private Limited is U24232AP2011PTC075293 and the company number is 075293 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Ran Bio-Pharma Private Limited was filed with the ROC on 31 Mar 2012.
Search company & director profiles for free and gain access to critical business data.